(16617218), D. O. K., (16617221), S. P., (16617224), Y. S., (16617227), M. J. S., (16617230), L. B., (11099556), J. O. B., & (16617233), J. L. (2025). Supplementary Table 2 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors.
Dyfyniad Arddull Chicago(16617218), David Olayinka Kamson, Sushant Puri (16617221), Yingying Sang (16617224), Meihui Jessica Shi (16617227), Lindsay Blair (16617230), Jaishri O. Blakeley (11099556), and John Laterra (16617233). Supplementary Table 2 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors. 2025.
Dyfyniad MLA(16617218), David Olayinka Kamson, et al. Supplementary Table 2 from Impact of Frontline Ivosidenib on Volumetric Growth Patterns in Isocitrate Dehydrogenase–mutant Astrocytic and Oligodendroglial Tumors. 2025.